CURAIZON

6.4

Concept,Applications

6.5/10

Field of Work

7.5/10

Deploy plan

5.8/10

Team,Popularity

7.0/10

Intelligent Rating

5.1/10

Ended-Oct 01, 2018 Rating-6.4/10

We’re solving an enormous real-world problem by helping patients take their medications properly, Curaizon™(CTKN) solves drug non-adherence problem by deploying our technology through national health services. As part of our solution, we collect fully anonymized data about how and when patients take medications. The value of a CuraToken™ is based on a real solution to a real problem.Curatoken could raise only 2806$

           #Medicare

Basic Details-Financials-
Name of ICOCuraizonToken –CTKN
WEBSITEcuraizon.compresale-No Info of Sale
Field of workHealthcareMainsale-Completed- 2806$
countryUKsoftcapNA
Pre-sale -Completedhardcap25,000,000 USD
Start-end2018-06-01 - 2018-06-08Total /max500,000,000 CTKN
Sale startJune 08, 2018Price usd-1 CTKN = 0.20 USD
Sale endsOct 01, 2018(Q4,18)Curr AcceptedETH
PlatformEthereumEth=/ethAppx. 1100 CTKN
TypeERC20Btc=/btcAppx. 32,000 CTKN
Algorithm usedNAMin buy500USD
KYC/WhitelistKYCToken Sale50%
Blockchain usedYesBonusesYes,
Nosale countryUSA1st Week - 20%2nd Week - 15%
3rd Week - 10%4th Week - 5%
Social details - fb twitter telegram bitcointalk medium linkedinWhitepaper Download Link

Lightpaper Download Link
Competition already existing - NYA
Uniqueness than competitors - Data Privacy
Unique selling point if any - Verifiability
Detailed intro of ICO


We’re solving an enormous real-world problem by helping patients take their medications properly
Every day, millions of people fail to take their medications as prescribed and the resulting personal and financial costs are staggering. Worldwide, non-adherence results in $700 billion in avoidable medical costs.
The data we create is unique and has enormous value to pharmaceutical companies, researchers and governments.
Every time a patient uses our CuraServe technology, our data grows in utility and value.
Curaizon™ solves drug non-adherence problem by deploying our technology through national health services. As part of our solution, we collect fully anonymized data about how and when patients take medications.
CuraTokens™ are the only way to access our data. Tokens can be redeemed to access the data, which will advance medical research, drive down healthcare costs and save lives.
The value of a CuraToken™ is based on a real solution to a real problem.

CuraServe™ Development Begins.
CuraServe™ Testing Underway.
CuraServe™ Alpha Release Complete.
Token Presale Begins.
Token Public Sale Begins.
CuraData™ Beta Release Complete.
CuraServe™ Public Release.
CuraData™ Platform Growth.
Curadata™ 2.0 Release.
Team


Nicholas James Rumble Chief Executive Officer (CEO)


Chris Matey
Chief Operations Officer (COO)



Mark Nathan
Chief Financial Officer (CFO)


Darran Trute
Chief Technology Officer (CTO)




Luke Lerdal
Chief Data Officer (CDO)


Andrey Verbitsky
Tokenomics Expert



Pencho Gavazov
Director of Business Development



Kristaps Kuhalskis
Creative Director

Advisors


Dr. Rory McCrea
MBBS, MSc, MRCGP



Sarah Chilvers
BSc, RGN, RHV, MBA, DProf


Paraexcel
Parexel
Biopharmaceutical service provider



James AJ Peters
Board Advisor



Dickie Armour
Board Advisor



Matthew Daniel
Board Advisor, CEO/Founder Coinonx

 

 

 

 

 

 

Curaizon

Curaizon

Spread the love

icomuch Author